Live animal ¸ðµ¨À» ÀÌ¿ëÇÑ Àν¶¸° ÀúÇ×¼º Æò°¡
- Á㠸𵨿¡¼ clamp ¿¬±¸-
|
|
È«Àº°æ
ÇѸ²ÀÇ´ë
|
Àν¶¸°ÀúÇ×¼ºÀº 1960³â S Yalow¿Í Berson µîÀÌ ´ç´¢º´È¯ÀÚ¿¡¼ Àν¶¸° ºÐºñ°¡ °¨¼ÒµÇ¾î ÀÖÀ» °ÍÀ̶õ Ãʱ⠿¹»ó°ú ´Þ¸® ³ôÀº Àν¶¸° ³óµµ¸¦ °üÂûÇÔÀ¸·Î½á óÀ½ º¸°íÇÏ¿´´Ù. Àν¶¸°ÀÌ Æ¯Á¤ Á¶Á÷¿¡¼ ÀûÀýÈ÷ ÀÛ¿ëÇÏÁö ¸øÇÏ´Â Çö»ó¿¡ µû¶ó Á¡ÁøÀûÀÎ Ç÷´ç »ó½ÂÀÇ ¿øÀÎÀÌ µÇ±âµµ ÇÏ´Â Àν¶¸° ÀúÇ×¼ºÀº Á¦2Çü ´ç´¢º´»Ó ¾Æ´Ï¶ó 1Çü ´ç´¢º´¿¡µµ µ¿¹ÝµÇ´Â Çö»óÀ¸·Î 1970³â´ë ¸¹Àº ¿¬±¸ÀÚµéÀÇ ÁÖ¿ä ¿¬±¸ °úÁ¦°¡ µÇ¾ú´Ù. Àν¶¸°ÀúÇ×¼ºÀ» ¿¬±¸ÇÏ´Â ¹æ¹ýÀº ÇöÀç »ç¶÷ ¹× µ¿¹°¿¡¼ ´Ù¾çÇÑ ¹æ¹ýµéÀÌ »ç¿ëµÇ°í ÀÖ´Ù. ±×·¯³ª ÇöÀç »ç¿ëÇÒ ¼ö ÀÖ´Â Àν¶¸°ÀúÇ×¼º ÃøÁ¤ ¹æ¹ýµéÀº ÀüüÀûÀÎ Çö»óÀ¸·Î½áÀÇ ¾çÀû ÃøÁ¤ÀÌ °¡´ÉÇÑ Á¤µµÀÌ¸ç ½ÇÁ¦ Àν¶¸°ÀúÇ×¼º ¹ß»ý¿¡¼ ÁÖ¿äÇÑ Àå±â ¹× Á¶Á÷µéÀÌ ¾î¶°ÇÑ ¿ªÇÒÀ» ÇÏ´ÂÁö ¾Ë ¼ö ¾ø´Ù. ´Ù¾çÇÑ Àν¶¸°ÀúÇ×¼º ÃøÁ¤ ¹æ¹ýµé Áß °íÀν¶¸° Á¤»óÇ÷´ç Ŭ·¥ÇÁ ¿¬±¸(hyperinsulinemic-euglycemic clamp technique)Àº ƯÈ÷ »ýü¿¡¼ ÀüüÀûÀÎ ±×¸®°í °¢ Àå±âº° Àν¶¸° ¹Î°¨µµ¸¦ ÃøÁ¤ÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀ¸·Î º» ¿öÅ©˜Þ¿¡¼´Â »ýÁã¿¡¼ÀÇ ½ÇÇèÀ» À§ÁÖ·Î ±× ¹æ¹ýÀ» ¼³¸íÇϰíÀÚ ÇÑ´Ù.
Clamp technique Àº internal jugular vein¿¡ °üÀ» ¿¬°áÇÏ¿© ¿ÜºÎ¿¡¼ Àν¶¸°, ´ç, ¹× ¹æ»ç¼± µ¿À§¿ø¼Ò°¡ °áÇÕµÈ ´çÀ» ÁÖÀÔÇÏ¿© Àν¶¸°¿¡ ÀÇÇÑ Àü½ÅÀû Æ÷µµ´ç ¼·Ãë ¹× Æ¯Á¤Á¶Á÷¿¡¼ÀÇ ÀÌ¿ë·üÀ» ÃøÁ¤ÇÒ ¼ö ÀÖÀ¸¸ç °£¿¡¼´Â ±âÀú»óÅ ¹× Àν¶¸° ÀÚ±ØÇÏ¿¡¼ÀÇ ´ç»ý¼ºÀ» ÃøÁ¤ÇÒ ¼ö ÀÖ´Ù.
1. »ýÁã ¼ö¼ú
Ŭ·¥ÇÁ ½ÇÇèÀ» À§ÇÑ »ýÁãµéÀº ½ÇÇè ¾à 5-7ÀÏ Àü internal jugular vein¿¡ silicone tube »ð°ü ¼ö¼úÀ» ½Ç½ÃÇÏ¿© °¢±â ´Ù¸¥ cage¿¡¼ ³Ö¾î ¼ö¼úÈÄ Ã¼Áß °¨¼Ò ¹× ½ºÆ®·¹½º¸¦ ȸº¹ÇÒ ¼ö ÀÖµµ·Ï À¯ÁöÇÑ´Ù. ¼ö¼úÀº »ýÁã ¹«°Ô¸¦ ÃøÁ¤ÇÏ¿© üÁß´ç °è»êµÈ ¸¶ÃëÁ¦(Ketamine: Xylazine mix)¸¦ º¹°À¸·Î ÁÖÀÔÇÏ°í »ýÁãÀÇ reflex µéÀÌ »ç¶óÁø ½ÃÁ¡¿¡ »ð°üÇϰíÀÚ ÇÏ´Â Internal jugular vein À§ÂÊ °æºÎÀÇ ÇǺθ¦ Á¶±Ý Àý°³Çϰí ÇÇÇÏ Á¶Á÷ ¹× Ç÷°ü ÁÖº¯ÀÇ Áö¹æÁ¶Á÷µéÀ» Á¦°ÅÇÏ¿© Ç÷°üÀÌ ³ëÃúµÇ¸é ¸Ó¸®ÂÊ ºÎÀ§¸¦ ¹¾î Ç÷¾× ¼øÈ¯À» Â÷´ÜÇÏ°í ½ÉÀåÂÊ¿¡¼ µé¾î¿À´Â ÂÊ Àº Àý°³ÇÏ¿© ¹Ì¸® ÁغñµÈ °üÀ» »ðÀÔÇϰí Ç÷°ü°ú ÇÔ²² ¹¾î °íÁ¤ÇÑ´Ù. µîÂÊ ¸ñ¿¡ °¡±î¿î ºÎÀ§¿¡ ÀÛÀº ±¸¸ÛÀ» ¸¸µé¾î Á¶½ÉÈ÷ ÇÇÇÏ·Î °üÀ» Åë°ú ½ÃÄÑ µîÀÇ Àý°³ÇÑ Æ´À¸·Î °üÀ» »©³»¾î ³¡Àº ½Ã·Î ¹Àº ÈÄ ´Ù½Ã ÇÇÇÏ¿¡ ³Ö¾î À¯ÁöÇÑ´Ù.
2. Ŭ·¥ÇÁ Áغñ ¹× ½ÇÇè ¹æ¹ý
Ŭ·¥ÇÁ¸¦ À§ÇÑ ½Ã·áµé Áß ¹æ»ç¼± µ¿À§¿ø¼Ò´Â ÃÖ¼Ò 2ÀÏÀü¿¡ (1) basal period infusion (F1): ÇÑ ¸¶¸®´ç À¯¸®°ü¿¡ 3H glucose 9 ?Ci¸¦ ³Ö°í ¿ë¸ÅÁõ¹ß, (2) clamp infusion (F2): ÇÑ ¸¶¸®´ç À¯¸®°ü¿¡ 3H glucose 18 ?Ci¸¦ ³Ö°í ¿ë¸ÅÁõ¹ß, (3) 3H glucose´Â ¿ë¸Å Áõ¹ß ÈÄ °¢°¢ 600 ?lÀÇ saline ³Ö°í ³ìÀÓ, (4) 14C-DG: ÇÑ ¸¶¸®´ç injection ÇÏ´Â ¾çÀº 10 ?Ci/10 ?l. ¼¼³×¸¶¸® ¿ëÀ» °°ÀÌ Á¦ÀÛÇÏ¿© ¿©À¯ºÐÀ» ´õÇÏ¿© ÁÜ µîÀ» °¢°¢ ÁغñÇØ ³õ´Â´Ù. ½ÇÇè ´çÀÏ Ç÷¾× äÃ븦 À§Çؼ´Â Ç÷Àå ¹æ»ç¼± µ¿À§¿ø¼Ò (tracer) ºÐ¼®¿ë tube Áغñ·Ñ 500 ?l microcentrifuge tube¿¡ F1Àº, 80, 85, 90, 100, 110, 120À» marking Çϰí Áõ·ù¼ö 20 ?l¸¦ ³Ö¾îµÎ°í, F2´Â marking Çϰí Áõ·ù¼ö 60 ?l¸¦ ³Ö´Â´Ù.
Ŭ·¥ÇÁ ½ÇÇè ÇÏ·ç Àü³¯ Àú³á cage¿¡ ¹°À» Á¦¿ÜÇÑ ¸ÔÀ̸¦ ¸ðµÎ Á¦°ÅÇÏ¿© ¾à 12½Ã°£ Á¤µµ ±Ý½ÄÇÒ ¼ö ÀÖµµ·Ï °ü¸®ÇÑ´Ù.
½ÇÇè ´çÀÏ ³¯ »ýÁãµéÀº °¢°¢ ¿øÅëÇüÀÇ Åõ¸í °ü¼Ó¿¡ ³Ö¾î µµ¸Á°¡Áö ¸øÇϵµ·Ï À¯ÁöÇÏ°í µî¿¡ ³Ö¾îµÐ °üÀ» ²¨³»±â Three way connector¿¡ ¿¬°áÇÑ´Ù. ÁãÀÇ ²¿¸®¸¦ Àß¶ó Ç÷¾× ¾à 10-15??l¸¦ äÇ÷ (microhematocrit capillary tube ÀÌ¿ë)Çϰí ÅÂÀÌÇÁ¸¦ ºÙ¿© ÃâÇ÷ÀÌ µÇÁö ¾Êµµ·Ï ¸·¾ÆµÐ´Ù. äÃëÇÑ Ç÷¾×Àº ¿ø½ÉºÐ¸®ÇÏ¿© Ç÷ÀåÀ» ÁغñÇØ µÎ°í Àν¶¸° ÁÖÀԾ׿¡ ¼¯¾î ÁغñÇØµÐ´Ù.
ÀÌÈÄ 2 ½Ã°£ µ¿¾È F1À» microdialysis pump¸¦ ÀÌ¿ëÇÏ¿© ¼Óµµ 3.3 ?l/min·Î ÁÖÀÔÇϰí F1À» ÁÖÀÔÇÏ´Â µ¿¾È Àν¶¸°°ú F2¸¦ Á¦ÀÛÇÑ´Ù. Àν¶¸° ÁÖÀÔ¾×Àº Saline 990 ?l¿¡ Àν¶¸°(100 U/ml) 10 ?l³Ö¾î vortex (100 ¹è Èñ¼®)Çϰí Èñ¼®µÈ Àν¶¸°À» ´Ù½Ã µÎ ¹è Èñ¼®ÇÏ¿© ¿ø¾×ÀÇ 200¹è Èñ¼®µÈ Àν¶¸°À¸·Î Á¦ÀÛÇÏ¿© 1 ml syringe¿¡ loading (priming insulin)ÇÑ´Ù. 100 ¹è Èñ¼®µÈ Àν¶¸°Àº ½ÇÇèÇÏ´Â »ýÁãÀÇ BW (kg)¿¡ 455 °öÇÏ¿© ³ª¿Â ¾ç ¸¸ÅÀÇ ?l¸¦ ÆÄÀÌÆêÀ¸·Î Ç÷ÀåÀ» ¹Ì¸® ¼¯Àº F2¿¡ ³Ö°í vortexÇÏ¿© ÁغñÇØ µÐ´Ù.
Clamp ½ÃÀÛ 30ºÐÀü Ç¥ÁØÈ ¿ë¾× (150 mg/dl)À» »ç¿ëÇÏ¿© glucose analyzer 2¸¦ calculationÇϰí 2½Ã°£ µ¿¾ÈÀÇ F1ÁÖÀÔÀÌ ³¡³ ÈÄ Ã¤Ç÷ÇÏ¿© Ç÷´çÀ» ÃøÁ¤ÇÏ°í ±âÀú Àν¶¸° ¹× Áö¹æ ÃøÁ¤¿ë Ç÷¾×µµ äÃëÇÑ´Ù. PumpÀÇ ÁÖÀÔ ÁÖ»ç±â¸¦ 20% Æ÷µµ´ç ÁÖÀÔ¿ë ÁÖ»ç±â¿Í 200 ¹è Èñ¼®ÇÑ Àν¶¸°À» ³ÖÀº ÁÖ»ç±â·Î ±³Ã¼Çϰí Ŭ·¥ÇÁ¸¦ ½ÃÀÛÇÑ´Ù.
¸ÕÀú 3ºÐ°£ 200¹è Èñ¼®ÇÑ Àν¶¸°À» ÁÖÀÔÇÏ¸é¼ 20% Æ÷µµ´ç ¿ë¾×µµ ÇÔ²² ÁÖÀÔÇÑ ÈÄ, 3 ºÐ ÈÄ Àν¶¸°À» F2·Î ¹Ù²Ù°í pump ¼Óµµ´Â ´Ù½Ã 3.3 ?l/min·Î ¸ÂÃß°í 20% Æ÷µµ´çÀº °°Àº ¼Óµµ·Î Áö¼ÓÀûÀ¸·Î ÁÖÀÔÇÑ´Ù. ÀÌÈÄ 20, 40, 60, 70 ºÐ¿¡ äÇ÷ÇÏ¿© Ç÷´ç ÃøÁ¤ÇÏ¸é¼ Æ÷µµ´çÀÇ ÁÖÀÔ ¼Óµµ¸¦ Á¶Àý ÇÏ°Ô µÇ´Âµ¥ °¡´ÉÇÑ Á¤»óÇ÷´çÀ» À¯ÁöÇÏ°í Æ÷µµ´ç ÁÖÀÔ¼Óµµ¸¦ Å©°Ô º¯ÈÇÏÁö ¾Êµµ·Ï Á¶ÀýÇÏ´Â °ÍÀÌ °¡Àå Áß¿äÇÏ´Ù. Ŭ·¥ÇÁ ½ÃÀÛÈÄ 75 ºÐ¿¡ 14C deoxyglucose¸¦ ÁÖÀÔÇϰí 80, 85, 90, 100, 110, 120 ºÐ¿¡ tracer ÃøÁ¤¿ë Ç÷Àå 10 ?lÀ» äÃëÇÏ¿© ºÐ¼®Àü±îÁö -20 ¡É º¸°üÇϰí 100, 110, 120ºÐ¿¡ Ç÷´ç ÃøÁ¤ ¹× 100-120¿¡ clampÁßÀÇ Àν¶¸° ¹× Áö¹æ ÃøÁ¤¿ë Ç÷Àåµµ äÃëÇÏ¿© -80¡É¿¡ º¸°üÇÑ´Ù.
Ŭ·¥ÇÁ ½ÇÇèÀÌ ³¡³ »ýÁã´Â ¸¶Ãë¾à ÁÖÀÔÈÄ °¢°¢ÀÇ Á¶Á÷À» äÃëÇÏ¿© °ð ¹Ù·Î liquid nitrogen¿¡ ¾ó·Á¼ -80 ¡É º¸°üÇÑ´Ù. ½ÇÇè ÀÏ ¾òÀº Ç÷¾×µéÀº whole body glucose turn over¸¦ °áÁ¤Çϱâ À§ÇØ µÈ tracer ·®À» ÃøÁ¤ÇÏ°í ¹Ì¸® ÁغñÇØµÐ Á¶Á÷Àº anion exchange columnÀ» ÀÌ¿ëÇÏ¿© 14C-2-deoxyglucose-6 phosphate¸¦ ºÐ¸®ÇÔÀ¸·Î½á Á¶Á÷¿¡ ¼·ÃëµÈ Æ÷µµ´çÀ» ÃøÁ¤Çϰí Ç÷¾×³»ÀÇ µ¿À§¿ø¼Ò º¯È·®°ú ºñ±³ÇÏ¿© ÀÌ¿ë·üÀ» °è»êÇØ ³½´Ù.
Âü°í¹®Çå
- Hong EG, Ko HJ, Cho YR, Kim HJ, Ma Z, Yu TY, Friedline RH, Kurt-Jones E, Finberg R, Fischer MA, Granger EL, Norbury CC, Hauschka SD, Philbrick WM, Lee CG, Elias JA, Kim JK: Interleukin-10 Prevents Diet-Induced Insulin Resistance by Attenuating Macrophage and Cytokine Response in Skeletal Muscle. Diabetes. 2009 58(11): 2525-35
- Xue B, Kim YB, Lee A, Toschi E, Bonner-Weir S, Kahn CR, Neel BG, Kahn BB: Protein-tyrosine phosphatase 1B deficiency reduces insulin resistance and the diabetic phenotype in mice with polygenic insulin resistance. J Biol Chem 282(33):23829-40, 2007
- Delibegovic M, Zimmer D, Kauffman C, Rak K, Hong EG, Cho YR, Kim JK, Kahn BB, Neel BG, Bence KK: Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress. Diabetes 58(3):590-9, 2009
- Delibegovic M, Bence KK, Mody N, Hong EG, Ko HJ, Kim JK, Kahn BB, Neel BG: Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B. Mol Cell Biol. 27(21):7727-34, 2007
|
|